Trace:
Cutting-edge in vivo imaging
Using advanced in vivo small animal imaging techniques OmniCarta offers an unpresented ability to follow the biodistribution of drugs over a time course. Combined with serial blood biomarker analysis, this guides and informs decision making for multiplexed proteomic imaging of key tissues.
Together with our other technologies in the OmniCarta pipeline and our novel STENCIL AI-driven approach to tissue selection and analysis, there is no more cost effective and comprehensive approach to understanding potential off target drug toxicity.
Example data reproduced from one of our teams many high profile publications (https://doi.org/10.1021/acs.bioconjchem.2c00306)